Tel-Instrument Electronics (TIK) Posts Solid Growth; Helen of Troy (HELE) Above-Consensus Numbers


After the closing bell on Thursday, Tel-Instrument Electronics Corp. (NYSEMKT:TIK) said in its preliminary unaudited results that revenue for the second quarter fiscal 2016 soared 90% year-over-year to a record $6.8 million, while six months revenues increased 89% to $12.7 million versus the same period the prior year

TIK stock closed at $4.60 with a total volume of 3,004 shares traded during the day

Tel-Instrument Electronics, a leading designer and manufacturer of avionics test and measurement solutions, has 3.26M Shares Outstanding, Market Capitalization (intraday) of $14.98M and TIK stock 52-week range is between $3.82 and $6.65 per share



Shares of Helen of Troy Ltd. (Nasdaq:HELE) climbed more than 8% to touch a record high in the extended session Thursday after the company delivered stronger-than-expected quarterly revenue and profit in its financial results

For its second quarter fiscal 2016, Helen of Troy posted net sales of $369.1 million, a 15.4% increase year over year, and non-GAAP net income of $32.3 million, or $1.12 per diluted share, compared to non-GAAP net income of $28.5 million, or $0.99 per diluted share in the same quarter the prior year, topping the Capital IQ Consensus Estimate of $1.03 earnings per share on revenues of $337.67 million for the period

HELE stock finished the regular trading session at $94.76, down slightly $0.37 (or -0.39%).

Helen of Troy Ltd,  a leading global consumer products company, has 28.62M Shares Outstanding and Market Capitalization (intraday) of $2.71B


Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at